RSVIX | VISVX | RSVIX / VISVX | |
Total Expense Ratio | 0.86 | 0.19 | 453% |
Annual Report Gross Expense Ratio | 1.37 | 0.19 | 721% |
Fund Existence | 11 years | 27 years | - |
Gain YTD | -6.581 | 0.611 | -1,077% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 3000 | 3,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.27M | 56.4B | 0% |
Annual Yield % from dividends | 1.07 | 1.95 | 55% |
Returns for 1 year | -1.84 | 8.26 | -22% |
Returns for 3 years | 13.77 | 23.54 | 59% |
Returns for 5 years | 47.25 | 74.87 | 63% |
Returns for 10 years | 57.70 | 97.69 | 59% |
1 Day | |||
---|---|---|---|
STOCK / NAME | Price $ | Chg $ | Chg % |
VEON | 52.35 | 3.83 | +7.89% |
VEON Ltd | |||
NHPAP | 17.44 | 1.08 | +6.60% |
National Healthcare Properties Inc | |||
PAC | 239.81 | 6.52 | +2.79% |
Grupo Aeroportuario del Pacifico SAB de CV Amer Dep Shares (each rep 10 Ser B shares) | |||
ESQ | 94.23 | -0.40 | -0.42% |
Esquire Financial Holdings | |||
APLT | 0.44 | -0.03 | -6.54% |
Applied Therapeutics |